Global Rare Disease Diagnostics Market Size, Top Share, Growth, Forecast 2030

Download Free Sample

Market Segmentation

Rare Disease Diagnostics Market, Disease Type (2020-2030)

Gastroenterology Disease
Endocrine and Metabolism Disorders Disease
Cardiovascular Disorders
Neurology Disease
Hematology and Oncology Disease
Dermatology Disease

Rare Disease Diagnostics Market, Product Type (2020-2030)

Kits and Assays
Panels

Rare Disease Diagnostics Market, Sample Type (2020-2030)

DNA Sample
Buccal Swab Sample
Blood
Saliva

Rare Disease Diagnostics Market, Technology (2020-2030)

Next-Generation Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Microarrays

Rare Disease Diagnostics Market, Trait Type (2020-2030)

Inherited
Acquired

Rare Disease Diagnostics Market, Test Type (2020-2030)

Genetic Test
General Lab Test
Imaging Test

Rare Disease Diagnostics Market, Age Group (2020-2030)

Children Age
Adult Age

Rare Disease Diagnostics Market, End-User (2020-2030)

Hospital Laboratories
Diagnostics Laboratories
Genetic Testing Laboratories
Cancer Research Laboratories
Cancer Research Institutes
Universities Research Laboratories

Regional Rare Disease Diagnostics Market

North America
1. North America Rare Disease Diagnostics Market, Disease Type
  1. Gastroenterology Disease
  2. Endocrine and Metabolism Disorders Disease
  3. Cardiovascular Disorders
  4. Neurology Disease
  5. Hematology and Oncology Disease
  6. Dermatology Disease
2. North America Rare Disease Diagnostics Market, Product Type
  1. Kits and Assays
  2. Panels
3. North America Rare Disease Diagnostics Market, Sample Type
  1. DNA Sample
  2. Buccal Swab Sample
  3. Blood
  4. Saliva
4. North America Rare Disease Diagnostics Market, Technology
  1. Next-Generation Sequencing
  2. Whole Genome Sequencing
  3. Whole Exome Sequencing
  4. Microarrays
5. North America Rare Disease Diagnostics Market, Trait Type
  1. Inherited
  2. Acquired
6. North America Rare Disease Diagnostics Market, Test Type
  1. Genetic Test
  2. General Lab Test
  3. Imaging Test
7. North America Rare Disease Diagnostics Market, Age Group
  1. Children Age
  2. Adult Age
8. North America Rare Disease Diagnostics Market, End-User
  1. Hospital Laboratories
  2. Diagnostics Laboratories
  3. Genetic Testing Laboratories
  4. Cancer Research Laboratories
  5. Cancer Research Institutes
  6. Universities Research Laboratories
9. U.S.
  1. U.S. Rare Disease Diagnostics Market, Disease Type
    1. Gastroenterology Disease
    2. Endocrine and Metabolism Disorders Disease
    3. Cardiovascular Disorders
    4. Neurology Disease
    5. Hematology and Oncology Disease
    6. Dermatology Disease
  2. U.S. Rare Disease Diagnostics Market, Product Type
    1. Kits and Assays
    2. Panels
  3. U.S. Rare Disease Diagnostics Market, Sample Type
    1. DNA Sample
    2. Buccal Swab Sample
    3. Blood
    4. Saliva
  4. U.S. Rare Disease Diagnostics Market, Technology
    1. Next-Generation Sequencing
    2. Whole Genome Sequencing
    3. Whole Exome Sequencing
    4. Microarrays
  5. U.S. Rare Disease Diagnostics Market, Trait Type
    1. Inherited
    2. Acquired
  6. U.S. Rare Disease Diagnostics Market, Test Type
    1. Genetic Test
    2. General Lab Test
    3. Imaging Test
  7. U.S. Rare Disease Diagnostics Market, Age Group
    1. Children Age
    2. Adult Age
  8. U.S. Rare Disease Diagnostics Market, End-User
    1. Hospital Laboratories
    2. Diagnostics Laboratories
    3. Genetic Testing Laboratories
    4. Cancer Research Laboratories
    5. Cancer Research Institutes
    6. Universities Research Laboratories
10. Canada
Europe
1. Europe Rare Disease Diagnostics Market, Disease Type
  1. Gastroenterology Disease
  2. Endocrine and Metabolism Disorders Disease
  3. Cardiovascular Disorders
  4. Neurology Disease
  5. Hematology and Oncology Disease
  6. Dermatology Disease
2. Europe Rare Disease Diagnostics Market, Product Type
  1. Kits and Assays
  2. Panels
3. Europe Rare Disease Diagnostics Market, Sample Type
  1. DNA Sample
  2. Buccal Swab Sample
  3. Blood
  4. Saliva
4. Europe Rare Disease Diagnostics Market, Technology
  1. Next-Generation Sequencing
  2. Whole Genome Sequencing
  3. Whole Exome Sequencing
  4. Microarrays
5. Europe Rare Disease Diagnostics Market, Trait Type
  1. Inherited
  2. Acquired
6. Europe Rare Disease Diagnostics Market, Test Type
  1. Genetic Test
  2. General Lab Test
  3. Imaging Test
7. Europe Rare Disease Diagnostics Market, Age Group
  1. Children Age
  2. Adult Age
8. Europe Rare Disease Diagnostics Market, End-User
  1. Hospital Laboratories
  2. Diagnostics Laboratories
  3. Genetic Testing Laboratories
  4. Cancer Research Laboratories
  5. Cancer Research Institutes
  6. Universities Research Laboratories
9. U.K.
  1. U.K. Rare Disease Diagnostics Market, Disease Type
    1. Gastroenterology Disease
    2. Endocrine and Metabolism Disorders Disease
    3. Cardiovascular Disorders
    4. Neurology Disease
    5. Hematology and Oncology Disease
    6. Dermatology Disease
  2. U.K. Rare Disease Diagnostics Market, Product Type
    1. Kits and Assays
    2. Panels
  3. U.K. Rare Disease Diagnostics Market, Sample Type
    1. DNA Sample
    2. Buccal Swab Sample
    3. Blood
    4. Saliva
  4. U.K. Rare Disease Diagnostics Market, Technology
    1. Next-Generation Sequencing
    2. Whole Genome Sequencing
    3. Whole Exome Sequencing
    4. Microarrays
  5. U.K. Rare Disease Diagnostics Market, Trait Type
    1. Inherited
    2. Acquired
  6. U.K. Rare Disease Diagnostics Market, Test Type
    1. Genetic Test
    2. General Lab Test
    3. Imaging Test
  7. U.K. Rare Disease Diagnostics Market, Age Group
    1. Children Age
    2. Adult Age
  8. U.K. Rare Disease Diagnostics Market, End-User
    1. Hospital Laboratories
    2. Diagnostics Laboratories
    3. Genetic Testing Laboratories
    4. Cancer Research Laboratories
    5. Cancer Research Institutes
    6. Universities Research Laboratories
10. Germany
11. France
12. Spain
13. Italy
14. Russia
15. Nordic
16. Benelux
17. Rest of Europe
APAC
1. APAC Rare Disease Diagnostics Market, Disease Type
  1. Gastroenterology Disease
  2. Endocrine and Metabolism Disorders Disease
  3. Cardiovascular Disorders
  4. Neurology Disease
  5. Hematology and Oncology Disease
  6. Dermatology Disease
2. APAC Rare Disease Diagnostics Market, Product Type
  1. Kits and Assays
  2. Panels
3. APAC Rare Disease Diagnostics Market, Sample Type
  1. DNA Sample
  2. Buccal Swab Sample
  3. Blood
  4. Saliva
4. APAC Rare Disease Diagnostics Market, Technology
  1. Next-Generation Sequencing
  2. Whole Genome Sequencing
  3. Whole Exome Sequencing
  4. Microarrays
5. APAC Rare Disease Diagnostics Market, Trait Type
  1. Inherited
  2. Acquired
6. APAC Rare Disease Diagnostics Market, Test Type
  1. Genetic Test
  2. General Lab Test
  3. Imaging Test
7. APAC Rare Disease Diagnostics Market, Age Group
  1. Children Age
  2. Adult Age
8. APAC Rare Disease Diagnostics Market, End-User
  1. Hospital Laboratories
  2. Diagnostics Laboratories
  3. Genetic Testing Laboratories
  4. Cancer Research Laboratories
  5. Cancer Research Institutes
  6. Universities Research Laboratories
9. China
  1. China Rare Disease Diagnostics Market, Disease Type
    1. Gastroenterology Disease
    2. Endocrine and Metabolism Disorders Disease
    3. Cardiovascular Disorders
    4. Neurology Disease
    5. Hematology and Oncology Disease
    6. Dermatology Disease
  2. China Rare Disease Diagnostics Market, Product Type
    1. Kits and Assays
    2. Panels
  3. China Rare Disease Diagnostics Market, Sample Type
    1. DNA Sample
    2. Buccal Swab Sample
    3. Blood
    4. Saliva
  4. China Rare Disease Diagnostics Market, Technology
    1. Next-Generation Sequencing
    2. Whole Genome Sequencing
    3. Whole Exome Sequencing
    4. Microarrays
  5. China Rare Disease Diagnostics Market, Trait Type
    1. Inherited
    2. Acquired
  6. China Rare Disease Diagnostics Market, Test Type
    1. Genetic Test
    2. General Lab Test
    3. Imaging Test
  7. China Rare Disease Diagnostics Market, Age Group
    1. Children Age
    2. Adult Age
  8. China Rare Disease Diagnostics Market, End-User
    1. Hospital Laboratories
    2. Diagnostics Laboratories
    3. Genetic Testing Laboratories
    4. Cancer Research Laboratories
    5. Cancer Research Institutes
    6. Universities Research Laboratories
10. Korea
11. Japan
12. India
13. Australia
14. Taiwan
15. South East Asia
16. Rest of Asia-Pacific
Middle East and Africa
1. Middle East and Africa Rare Disease Diagnostics Market, Disease Type
  1. Gastroenterology Disease
  2. Endocrine and Metabolism Disorders Disease
  3. Cardiovascular Disorders
  4. Neurology Disease
  5. Hematology and Oncology Disease
  6. Dermatology Disease
2. Middle East and Africa Rare Disease Diagnostics Market, Product Type
  1. Kits and Assays
  2. Panels
3. Middle East and Africa Rare Disease Diagnostics Market, Sample Type
  1. DNA Sample
  2. Buccal Swab Sample
  3. Blood
  4. Saliva
4. Middle East and Africa Rare Disease Diagnostics Market, Technology
  1. Next-Generation Sequencing
  2. Whole Genome Sequencing
  3. Whole Exome Sequencing
  4. Microarrays
5. Middle East and Africa Rare Disease Diagnostics Market, Trait Type
  1. Inherited
  2. Acquired
6. Middle East and Africa Rare Disease Diagnostics Market, Test Type
  1. Genetic Test
  2. General Lab Test
  3. Imaging Test
7. Middle East and Africa Rare Disease Diagnostics Market, Age Group
  1. Children Age
  2. Adult Age
8. Middle East and Africa Rare Disease Diagnostics Market, End-User
  1. Hospital Laboratories
  2. Diagnostics Laboratories
  3. Genetic Testing Laboratories
  4. Cancer Research Laboratories
  5. Cancer Research Institutes
  6. Universities Research Laboratories
9. UAE
  1. UAE Rare Disease Diagnostics Market, Disease Type
    1. Gastroenterology Disease
    2. Endocrine and Metabolism Disorders Disease
    3. Cardiovascular Disorders
    4. Neurology Disease
    5. Hematology and Oncology Disease
    6. Dermatology Disease
  2. UAE Rare Disease Diagnostics Market, Product Type
    1. Kits and Assays
    2. Panels
  3. UAE Rare Disease Diagnostics Market, Sample Type
    1. DNA Sample
    2. Buccal Swab Sample
    3. Blood
    4. Saliva
  4. UAE Rare Disease Diagnostics Market, Technology
    1. Next-Generation Sequencing
    2. Whole Genome Sequencing
    3. Whole Exome Sequencing
    4. Microarrays
  5. UAE Rare Disease Diagnostics Market, Trait Type
    1. Inherited
    2. Acquired
  6. UAE Rare Disease Diagnostics Market, Test Type
    1. Genetic Test
    2. General Lab Test
    3. Imaging Test
  7. UAE Rare Disease Diagnostics Market, Age Group
    1. Children Age
    2. Adult Age
  8. UAE Rare Disease Diagnostics Market, End-User
    1. Hospital Laboratories
    2. Diagnostics Laboratories
    3. Genetic Testing Laboratories
    4. Cancer Research Laboratories
    5. Cancer Research Institutes
    6. Universities Research Laboratories
10. Turkey
11. Saudi Arabia
12. South Africa
13. Egypt
14. Nigeria
15. Rest of MEA
LATAM
1. LATAM Rare Disease Diagnostics Market, Disease Type
  1. Gastroenterology Disease
  2. Endocrine and Metabolism Disorders Disease
  3. Cardiovascular Disorders
  4. Neurology Disease
  5. Hematology and Oncology Disease
  6. Dermatology Disease
2. LATAM Rare Disease Diagnostics Market, Product Type
  1. Kits and Assays
  2. Panels
3. LATAM Rare Disease Diagnostics Market, Sample Type
  1. DNA Sample
  2. Buccal Swab Sample
  3. Blood
  4. Saliva
4. LATAM Rare Disease Diagnostics Market, Technology
  1. Next-Generation Sequencing
  2. Whole Genome Sequencing
  3. Whole Exome Sequencing
  4. Microarrays
5. LATAM Rare Disease Diagnostics Market, Trait Type
  1. Inherited
  2. Acquired
6. LATAM Rare Disease Diagnostics Market, Test Type
  1. Genetic Test
  2. General Lab Test
  3. Imaging Test
7. LATAM Rare Disease Diagnostics Market, Age Group
  1. Children Age
  2. Adult Age
8. LATAM Rare Disease Diagnostics Market, End-User
  1. Hospital Laboratories
  2. Diagnostics Laboratories
  3. Genetic Testing Laboratories
  4. Cancer Research Laboratories
  5. Cancer Research Institutes
  6. Universities Research Laboratories
9. Brazil
  1. Brazil Rare Disease Diagnostics Market, Disease Type
    1. Gastroenterology Disease
    2. Endocrine and Metabolism Disorders Disease
    3. Cardiovascular Disorders
    4. Neurology Disease
    5. Hematology and Oncology Disease
    6. Dermatology Disease
  2. Brazil Rare Disease Diagnostics Market, Product Type
    1. Kits and Assays
    2. Panels
  3. Brazil Rare Disease Diagnostics Market, Sample Type
    1. DNA Sample
    2. Buccal Swab Sample
    3. Blood
    4. Saliva
  4. Brazil Rare Disease Diagnostics Market, Technology
    1. Next-Generation Sequencing
    2. Whole Genome Sequencing
    3. Whole Exome Sequencing
    4. Microarrays
  5. Brazil Rare Disease Diagnostics Market, Trait Type
    1. Inherited
    2. Acquired
  6. Brazil Rare Disease Diagnostics Market, Test Type
    1. Genetic Test
    2. General Lab Test
    3. Imaging Test
  7. Brazil Rare Disease Diagnostics Market, Age Group
    1. Children Age
    2. Adult Age
  8. Brazil Rare Disease Diagnostics Market, End-User
    1. Hospital Laboratories
    2. Diagnostics Laboratories
    3. Genetic Testing Laboratories
    4. Cancer Research Laboratories
    5. Cancer Research Institutes
    6. Universities Research Laboratories
10. Mexico
11. Argentina
12. Chile
13. Colombia
14. Rest of LATAM

Related Reports

Autoimmune Disease Diagnostics Market

Global Report

The global autoimmune disease diagnostics market size was valued at USD 4,253.29 million in 2021 and is anticipated to generate 8089.97 million by 2030. The market is projected to grow at a CAGR of 7.17% during the forecast period (2022–2030).

Buy Now

Malaria Diagnostics Market

Global Report

The Total Addressable Market (TAM) for Malaria Diagnostics was valued at USD 762.19 million in 2022. It is estimated to reach an expected value of USD 1192.58 million by 2031, registering a CAGR of 5.1% during the forecast period (2023-2031). In rec

Buy Now

Remote Diagnostics Market

Global Report

The global remote diagnostics market size was valued at USD 41.3 billion in 2023. It is expected to reach USD 121.3 billion by 2032, growing at a CAGR of 31.8% during the forecast period (2024–2032). Remote diagnostics, also known as

Buy Now

Sepsis Diagnostics Market

Global Report

The global sepsis diagnostics market size was valued at USD 685 million in 2022. It is expected to reach USD 1,427.44 million by 2031 at a CAGR of 8.5% during the projected period (2023–2031). Factors such as increasing prevalence of

Buy Now

Transplant Diagnostics Market

Global Report

The global transplant diagnostics market size was valued at USD 3,550 million in 2019 and is expected to grow with a CAGR of 7.4% during the forecast period, 2020–2029. Organ transplantation is a surgical procedure of removing healthy org

Buy Now

Purchase Benefits

Eligible for a free updated report next year
Completely customizable scope
30% discount on your next purchase
Dedicated account manager
Query resolution within 24 hours
Permission to print the report

Study Period	2018-2030	CAGR	8.62%
Historical Period	2018-2020	Forecast Period	2022-2030
Base Year	2021	Base Year Market Size	USD 33.83 Billion
Forecast Year	2030	Forecast Year Market Size	USD 71.2 Billion
Largest Market	North America	Fastest Growing Market	Asia Pacific

Rare Disease Diagnostics Market

Market Segmentation

Related Reports

Purchase Benefits

We are featured on :

Sample Details